Internal controls order

Ended Awarded Last action

Contract number
75F40120F19001
Awardee
Awarding agency
Obligated
$7,328,325

Award facts

Contract value 100% obligated
$7,328,325.46 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Arlington, VA 22209, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 -$1,013,342
Terminate for Convenience P00007 · EOI::defend the spend::EOI termination for convenience agreement $0
Exercise an Option P00006 $1,823,615
Exercise an Option P00005 $1,787,834
Exercise an Option P00004 · Maturing the internal controls system at FDA blanket purchase agreement (BPA) $1,752,768
Other Administrative Action P00003 · Modification to incorporate IPP clause $0
Exercise an Option P00002 $1,718,400
Supplemental Agreement for work within scope P00001 $0
Original award $1,259,050

About this award

This federal contract award was issued by the Food and Drug Administration (FDA) to Deloitte & Touche LLP, a prominent professional services firm, for an INTERNAL CONTROLS ORDER. The contract is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle, with a ceiling value of $7,328,325.46 and a period of performance through May 14, 2025. This award was not set aside for any specific business type.

Deloitte, as the prime contractor, will provide a range of professional services to the FDA, including financial management, IT modernization, cybersecurity, program management, identity and access management, audit remediation, and strategic consulting support. The company frequently collaborates with small business subcontractors to enhance its service delivery capabilities. Deloitte holds several significant BPA and Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicles across federal agencies, demonstrating its broad capabilities and extensive government partnerships.

Quick answers

Who was awarded contract 75F40120F19001?

75F40120F19001 was awarded to Deloitte & Touche LLP by Food and Drug Administration (Department of Health and Human Services) on August 14, 2020.

How much is contract 75F40120F19001 worth?

The government has obligated $7,328,325 on 75F40120F19001.

Is contract 75F40120F19001 an order under another contract?

Yes. 75F40120F19001 is a BPA call under GS00F029DA-75F40120A00023, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40120F19001 competed?

The extent of competition for 75F40120F19001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award